Transnasal Delivery of Low Level Light Via the Sphenoidal Sinus to Irradiate the Substantia Nigra
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Mar 30, 2017
app pub date -
Sep 28, 2015
filing date -
Sep 28, 2015
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
A transnasal delivery method for treating or preventing Parkinson's disease using photobiomodulation. An optical system is provided including a light source and an optical fiber. The optical system is advanced through the nasal cavity until a distal end of the optical fiber is positioned inside the sphenoidal sinus. Then the light source is activated to irradiate substantia nigra brain tissue with an effective amount of light in the treatment or prevention of Parkinson's disease.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully